Issues
July 2009 CLINICAL
- Lipid Profile Changes Associated With Changing Available Formulary Statins: Removing Higher Potency Agents
Daniel S. Longyhore, PharmD; Casey McNulty Stockton, PharmD; and Marie Roke Thomas, PhD With the exception of high-density lipoprotein cholesterol, fasting lipid profiles were not significantly changed after higher potency statins were removed from prescription formularies.  Full Text PDF
- Adherence to Osteoporosis Medications After Patient and Physician Brief Education: Post Hoc Analysis of a Randomized Controlled Trial
Aimee Der-Huey Shu, MD; Margaret R. Stedman, MPH; Jennifer M. Polinski, MPH, MS; Saira A. Jan, MS, PharmD; Minal Patel, MD, MPH; Colleen Truppo, RN, MBA; Laura Breiner, RN, BSN; Ya-ting Chen, PhD; Thomas W. Weiss, DrPH; and Daniel H. Solomon, MD, MPH Post hoc analysis of a randomized controlled trial found that a 1-session educational intervention targeted at patients and primary care physicians did not improve osteoporosis medication adherence.
- Automated Messaging to Improve Compliance With Diabetes Test Monitoring
Stephen F. Derose, MD, MS; Randall K. Nakahiro, PharmD; and Frederick H. Ziel, MD A randomized controlled trial was conducted to compare the effectiveness of automated telephone and mail outreach to prompt compliance with periodic diabetes laboratory testing. POLICY
- Medicaid Beneficiaries With Congestive Heart Failure: Association of Medication Adherence With Healthcare Use and Costs
Dominick Esposito, PhD; Ann D. Bagchi, PhD; James M. Verdier, JD; Deo S. Bencio, BS; and Myoung S. Kim, PhD Higher medication adherence among Medicaid beneficiaries with congestive heart failure was associated with lower healthcare utilization and lower costs, and the relationship to costs was graded.
- Medication Adherence and Use of Generic Drug Therapies
Becky A. Briesacher, PhD; Susan E. Andrade, ScD; Hassan Fouayzi, MS; and K. Arnold Chan, MD Generic prescribing was associated with improved medication adherence in 2 of 5 study conditions, but $0 copayments were associated with improved adherence across all conditions. METHODS
- Measuring Concurrent Adherence to Multiple Related Medications
Niteesh K. Choudhry, MD, PhD; William H. Shrank, MD, MSHS; Raisa L. Levin, MS; Joy L. Lee, BA; Saira A. Jan, MS, PharmD; M. Alan Brookhart, PhD; and Daniel H. Solomon, MD, MPH This study compares the performance of several definitions of concurrent adherence to related medications. WEB EXCLUSIVE CONTENT
- A Multiattribute Decision Model for Bipolar Disorder: Identification of Preferred Mood-Stabilizing Medications
Brandon T. Suehs, PharmD; and Tawny L. Bettinger, PharmD, BCPP This research develops a multiattribute decision model to aid in the selection of preferred mood-stabilizing agents for the treatment of bipolar disorder.
- Impact of Workplace Health Services on Adherence to Chronic Medications
Bruce W. Sherman, MD; Sharon Glave Frazee, PhD; Raymond J. Fabius, MD, CPE; Rochelle A. Broome, MD; James R. Manfred, RPh; and Jeffery C. Davis, MBA Patients who used workplace primary care and pharmacy services had higher adherence rates to medications for their chronic conditions than community-treated patients.
|
|
